Does nanobiotechnology create new tools to combat microorganisms?
Source abstract
Abstract
Abstract Antimicrobial resistance is still a crucial global problem related to the overuse of antibiotics and natural microorganism capability for rapid horizontal evolution. Even new generations of drugs are not able to overcome bacterial defence mechanisms. A novel solution for this immense medical challenge can be nanomaterials. Researchers indicate that modern nanoforms can effectively support and perhaps in the long-term replace traditional bactericidal agents. Because of their unique physicochemical properties, nanotechnology products can exert multiple actions against bacteria, which might be efficient against even multidrug-resistant pathogens. In this review, we discuss the documented achievements and concerns associated with broad potential applications of nanoforms in the fight against microorganisms.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nanotechnology research and applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
1Neuroendocrinology Department, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabłonna, Poland
2Department of Animal Nutrition and Biotechnology, Warsaw University of Life Sciences, Ciszewskiego 8 Warsaw, 02-786, Poland
3Endocrinology Department, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabłonna, Poland
4Department of Large Animal Sciences, University of Copenhagen, Groennegaardsvej 3, 1870 Frederiksberg C, Denmark
References (100+)
Show source-provided references
1. Bacterial motility on a surface: many ways to a common goal10.1146/annurev.micro.57.030502.091014 ↗
2. Fluoroquinolones: structure and target sites10.2174/1389450033346920 ↗
3. Nanoparticles as drug delivery systems in cancer medicine: emphasis on RNAi-containing nanoliposomes10.3390/ph6111361 ↗
4. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles10.1021/nn300934k ↗
5. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids)
6. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles10.3390/polym3010340 ↗
7. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats10.1016/j.biomaterials.2013.06.048 ↗
8. Nanoparticle dermal absorption and toxicity: a review of the literature10.1007/s00420-009-0458-x ↗
9. Antibiofilm surface functionalisation of catheters by magnesium fluoride nanoparticles
10. Visualisation of interaction between inorganic nanoparticles and bacteria or fungi
11. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment10.1007/s11051-010-9900-y ↗
12. Functional materials in food nanotechnology10.1111/j.1750-3841.2006.00195.x ↗
13. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation
14. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles10.1021/nn300934k ↗
15. Safety and risk associated with nanoparticles-a review
16. The release of nanosilver from consumer products used in the home10.2134/jeq2009.0363 ↗
17. Microbiological aspects of slurry management
18. Visualisation of interaction between inorganic nanoparticles and bacteria or fungi
19. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy10.1039/c2cs15260f ↗
20. Nanoalumina promotes the horizontal transfer of multi-resistance genes mediated by plasmids across genera10.1073/pnas.1107254109 ↗
21. Antibiotic resistance: an overview of mechanisms and a paradigm shift
22. Toxicological effect of ZnO nanoparticles based on bacteria10.1021/la7035949 ↗
23. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
24. Investigations of the antibacterial properties of ciprofloxacin@SiO210.1021/la061411h ↗
25. Nanoinformatics: a new area of research in nanomedicine
26. The role of nitric oxide in inflammatory reactions10.1111/j.1574-695X.2007.00329.x ↗
27. Size-controlled silver nanoparticles synthesised over the range 5–100 nm using the same protocol and their antibacterial efficacy10.1039/C3RA44507K ↗
28. Bactericidal actions of a silver ion solution on Escherichia coli studied by energy-filtering transmission electron microscopy and proteomic analysis10.1128/AEM.71.11.7589-7593.2005 ↗
29. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
30. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal10.1007/s00253-010-2468-8 ↗
31. Nanoparticles functionalised with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus10.1128/AEM.06513-11 ↗
32. Antimicrobial effect of chitosan nanoparticles on Streptococcus mutans biofilms10.1128/AEM.02941-10 ↗
33. Visualisation of morphological interaction of diamond and silver nanoparticles with Salmonella enteritidis and Listeria monocytogenes.10.1166/jnn.2011.4735 ↗
34. Graphene-based antibacterial paper
35. Microbiological aspects of slurry management
36. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation
37. Mechanisms of bacterial biocide and antibiotic resistance10.1046/j.1365-2672.92.5s1.8.x ↗
38. 2010 · 845
39. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles10.1021/nl504798g ↗
40. Silver nanoparticle impregnated biomedical fibre
41. Antimicrobial biomaterials based on carbon nanotubes dispersed in poly(lactic-co-glycolic acid)10.1039/c0nr00329h ↗
42. Malcata, FX In vitro screening for anti-microbial activity of chitosans and chitooligosaccharides, aiming at potential uses in functional textiles10.4014/jmb.0904.04038 ↗
43. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development10.1016/j.joen.2011.02.007 ↗
44. On the toxicity of therapeutically used nanoparticles: an overview
45. Nanoparticles functionalised with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus10.1128/AEM.06513-11 ↗
46. Recent advances in graphene family materials toxicity investigations10.1007/s11051-012-1320-8 ↗
47. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment10.1007/s11051-010-9900-y ↗
48. Toxic effects of gold nanoparticles on Salmonella Typhimurium bacteria10.1177/0748233710393395 ↗
49. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamycin nanoliposomes in methicillin-resistant Staphylococcus aureus10.3109/03639045.2014.920025 ↗
50. The immunomodulatory and anti-inflammatory properties
51. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria10.1021/ja1028843 ↗
52. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamycin nanoliposomes in methicillin-resistant Staphylococcus aureus10.3109/03639045.2014.920025 ↗
53. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulphonamide resistance10.1042/BJ20071598 ↗
54. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology10.4161/viru.2.3.16161 ↗
55. Quorum sensing: the power of cooperation in the world of Pseudomonas.10.1111/j.1462-2920.2005.00769.x ↗
56. The effect of nanoparticle size, shape, and surface chemistry on biological systems10.1146/annurev-bioeng-071811-150124 ↗
57. Adsorption mechanisms of organic chemicals on carbon nanotubes10.1021/es801777n ↗
58. Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay10.1016/j.chemosphere.2009.12.056 ↗
59. Preparation and antibacterial activity of chitosan nanoparticles10.1016/j.carres.2004.09.007 ↗
60. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens10.1038/jid.2012.399 ↗
61. Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay10.1016/j.chemosphere.2009.12.056 ↗
62. Transport of drugs across the blood–brain barrier by nanoparticles10.1016/j.jconrel.2011.08.017 ↗
63. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats10.1016/j.biomaterials.2013.06.048 ↗
64. Inactivation of bacterial pathogens by carbon nanotubes in suspensions10.1021/la802769m ↗
65. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections10.1128/AAC.01803-10 ↗
66. Investigations of the antibacterial properties of ciprofloxacin@SiO210.1021/la061411h ↗
67. An index for characterisation of nanomaterials in biological systems10.1038/nnano.2010.164 ↗
68. Ciprofloxacin-protected gold nanoparticles10.1021/la0358567 ↗
69. Nanotoxicology: nanoparticles versus the placenta10.1038/nnano.2011.65 ↗
70. Biosensing, cytotoxicity, and cellular uptake studies of surface-modified gold nanorods
71. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles10.1016/j.biomaterials.2009.01.052 ↗
72. The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice10.1016/j.niox.2006.04.002 ↗
73. The bacterial cell envelope
74. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles10.3390/polym3010340 ↗
75. Nanotechnology-based drug delivery systems10.1186/1745-6673-2-16 ↗
76. Nanodiamond particles: properties and perspectives for bioapplications10.1080/10408430902831987 ↗
77. 2010 · 845
78. Silver nanoparticle impregnated biomedical fibre
79. The use of nanoparticles in anti-microbial materials and their characterisation10.1039/b715532h ↗
80. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy10.1039/c2cs15260f ↗
81. Mechanisms of bacterial resistance to antimicrobial agents10.1093/ajhp/54.12.1420 ↗
82. Enhanced bioactivity of ZnO nanoparticles – an antimicrobial study
83. Comparative photoactivity and antibacterial properties of C60 fullerenes and titanium dioxide nanoparticles10.1021/es803093t ↗
84. Carbon nanotubes: present and future commercial applications10.1126/science.1222453 ↗
85. Antimicrobial properties of chitosan and mode of action: a state of the art review10.1016/j.ijfoodmicro.2010.09.012 ↗
86. Nanoparticle-based theranostic agents10.1016/j.addr.2010.07.009 ↗
87. Mechanisms of bacterial biocide and antibiotic resistance10.1046/j.1365-2672.92.5s1.8.x ↗
88. 2007 · 37
89. Influence of particle size on the antibacterial activity of zinc oxide10.1016/S1466-6049(01)00197-0 ↗
90. Anti-biofilm activity of nanosized magnesium fluoride10.1016/j.biomaterials.2009.07.037 ↗
91. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress10.1021/nn202451x ↗
92. Mechanism of antibacterial activity of copper nanoparticles10.1088/0957-4484/25/13/135101 ↗
93. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria10.1016/j.jcis.2004.02.012 ↗
94. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria10.1016/j.nano.2009.04.006 ↗
95. Multifunctional Fe3O4@ Au nanoeggs as photothermal agents for selective killing of nosocomial and antibiotic-resistant bacteria10.1002/smll.200801042 ↗
96. An index for characterisation of nanomaterials in biological systems10.1038/nnano.2010.164 ↗
97. Adsorption mechanisms of organic chemicals on carbon nanotubes10.1021/es801777n ↗
98. Stability, bioavailability, and bacterial toxicity of ZnO and iron-doped ZnO nanoparticles in aquatic media
99. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells10.1016/j.chemosphere.2011.01.025 ↗
100. Synergistic antibacterial activity of chitosan–silver nanocomposites on Staphylococcus aureus.10.1088/0957-4484/22/13/135101 ↗